Humasis Co. Ltd. (KOSDAQ:205470)
2,370.00
+65.00 (2.82%)
Jul 1, 2026, 3:30 PM KST
Humasis Revenue
Humasis had revenue of 8.92B KRW in the quarter ending March 31, 2026, with 44.76% growth. This brings the company's revenue in the last twelve months to 32.87B, up 10.65% year-over-year. In the year 2025, Humasis had annual revenue of 30.11B with 18.49% growth.
Revenue (ttm)
32.87B
Revenue Growth
+10.65%
P/S Ratio
1.63
Revenue / Employee
547.87M
Employees
60
Market Cap
53.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.11B | 4.70B | 18.49% |
| Dec 31, 2024 | 25.41B | 11.59B | 83.79% |
| Dec 31, 2023 | 13.83B | -457.45B | -97.07% |
| Dec 31, 2022 | 471.27B | 149.44B | 46.44% |
| Dec 31, 2021 | 321.83B | 276.11B | 603.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 122.78B |
| Osang Healthcare Co.,Ltd | 119.38B |
| Ray Co., Ltd. | 112.53B |
| LabGenomics | 84.19B |
| T&R Biofab | 29.73B |
| HASS Corp. | 16.58B |
| Access Bio | 14.94B |
| Sugentech | 9.87B |